thereof resulted primarily from the company prepare for listing on the Stock Exchange of Thailand included the creation of a team of internal auditors; effective internal control system of the company and
President The Stock Exchange of Thailand Rajthanee Hospital Public Company Limited (“the Company”) would like to clarify the operating results of the Company and its subsidiaries for the 2nd quarter of 2018
0 1 8 but later terminated the contract with the distributor which is effective on 3 0 June 2 0 1 9 . During the period, the Company was unable to make any sales through traditional trade channel or
shareholder in the amount of USD 9.51 million. The Company additionally received opportunity cost in the amount of Baht 10 million. Such sale of shares is a termination of joint investment for the development
cost of borrowing slightly increased from 2.6% to 2.8% affected by rising interest rates. Income Tax was at Bt6,168mn, increased 3.3%YoY. The effective tax rate was 19.2% increasing from 18.1% in FY21
cost control. Consequently, sales expenses to sales revenue ratio dropped from 48.01% to 42.26% as the Company held up the sales, sale promotion, and marketing expenses. Table 6: Sales Expenses by Type
-month period ended 31 March 2019, the Company and its subsidiaries have adopted TFRS 15 “Revenue from Contracts with Customers” which become effective for fiscal years beginning on or after 1 January 2019
TOT partnership cost” . As the agreement is effective from Jan-2019, the revenue and cost of rent incurred for 9-month period are recorded in 3Q19 offsetting the actual cost previously paid to TOT in
transportation service revenue is slightly decreased from the previous year but gross profit of the Company is not different from the same period of last year since the Company is able to manage better cost of